Caturra Coffee (Coffea arabica)

Caturra is a natural dwarf mutation of Coffea arabica first identified in Brazil, containing caffeine, chlorogenic acids, and diterpenes cafestol and kahweol as its primary bioactive compounds. These compounds modulate adenosine receptors, antioxidant enzymes, and lipid metabolism pathways, producing effects consistent with broader C. arabica research rather than Caturra-specific evidence.

Origin & History

Caturra is a dwarf cultivar variant of Coffea arabica (Arabica coffee), originating as a natural mutation of the Bourbon variety discovered in Brazil in the 1930s and popularized in Central America. It is sourced from compact C. arabica plants that produce coffee beans typically harvested at altitudes of 700-1800 meters, with optimal growth in Latin America enabling high-density planting up to 10,000 plants per hectare. Standard coffee processing methods apply (washed, natural, or anaerobic fermentation), with no unique extraction methods specific to this cultivar.

Historical & Cultural Context

Caturra has no documented historical use in traditional medicine systems, as it is a modern agricultural cultivar developed in the 20th century for yield and flavor rather than medicinal purposes. While general Coffea arabica has traditional uses in Ethiopian and Yemeni systems for stimulation, Caturra-specific traditional evidence is absent. The cultivar was developed primarily for agricultural efficiency and sensory qualities like citrus and cacao flavor notes.

Health Benefits

• No clinical evidence exists specifically for Caturra coffee health benefits - only general C. arabica research applies
• General coffee consumption (3-5 cups/day) associated with cardiovascular benefits - evidence quality: not established for Caturra specifically
• Contains standard coffee compounds like caffeine (1-2%) and chlorogenic acids - evidence quality: compositional data only
• May share general C. arabica antioxidant properties from polyphenols - evidence quality: no Caturra-specific studies
• Potential cognitive benefits through caffeine content affecting adenosine receptors - evidence quality: mechanism inferred from general coffee research

How It Works

Caffeine in Caturra coffee competitively antagonizes adenosine A1 and A2A receptors in the central nervous system, increasing dopaminergic and noradrenergic neurotransmission to enhance alertness and reduce perceived fatigue. Chlorogenic acids, primarily 5-caffeoylquinic acid, inhibit glucose-6-phosphatase and slow intestinal glucose absorption, contributing to modest glycemic modulation. Diterpenes cafestol and kahweol act as ligands for farnesoid X receptor and pregnane X receptor, influencing bile acid metabolism and hepatic enzyme induction, which partly explains their dual antioxidant and cholesterol-raising properties.

Scientific Research

No clinical trials, RCTs, or meta-analyses specific to Caturra coffee were identified in PubMed-indexed studies. General Coffea arabica research exists on coffee compounds like caffeine and chlorogenic acids, but no human studies differentiate Caturra by cultivar. One agronomic study characterized C. arabica parent plants including Caturra roja for morphological traits, but lacks clinical outcomes (PMID unavailable).

Clinical Summary

No randomized controlled trials or observational studies have been conducted specifically on Caturra coffee as a distinct cultivar; all clinical inferences are extrapolated from general Coffea arabica and pooled coffee research. A 2012 meta-analysis of 36 prospective cohort studies (N > 1,200,000) found habitual coffee consumption of 3–5 cups/day associated with a roughly 15% reduction in cardiovascular disease risk, though cultivar composition was not controlled. Chlorogenic acid supplementation trials using 140–720 mg/day have demonstrated statistically significant but modest reductions in systolic blood pressure (3–4 mmHg) and fasting glucose in pre-diabetic adults. Evidence strength for Caturra-specific health claims is currently nonexistent, and any benefits attributed to it rely entirely on chemical similarity to other C. arabica varieties.

Nutritional Profile

Caturra coffee beans (green, unroasted, per 100g dry weight) contain approximately 10-13% protein (primarily storage proteins and enzymes), 15-17% lipids (concentrated in the coffee oil/wax fraction, rich in diterpenes cafestol and kahweol at 0.2-0.8% of green bean weight), and 50-55% total carbohydrates (predominantly polysaccharides including galactomannans and arabinogalactans; sucrose ~6-9% in green beans, degrading significantly upon roasting). Dietary fiber content is approximately 33-40% of dry green bean weight (largely insoluble). As a C. arabica cultivar, Caturra shares the characteristic arabica caffeine range of 0.9-1.4% dry weight (lower than robusta's 1.7-4%), with trigonelline at 0.6-1.2% (a niacin precursor partially converted to niacin B3 during roasting). Chlorogenic acids (CGAs) are the dominant bioactive polyphenols at 5.5-8.0% of green bean dry weight, primarily 5-caffeoylquinic acid (5-CQA); roasting degrades CGAs by 50-95% depending on roast level. Roasted Caturra coffee (brewed, per 240ml cup) delivers approximately 80-120mg caffeine, 20-50mg CGAs, and trace minerals including magnesium (~7mg), potassium (~116mg), and niacin (~0.5mg). Lipid bioavailability is brew-method dependent: paper-filtered coffee retains <0.1mg/cup diterpenes, while unfiltered (French press, espresso) delivers 2-4mg cafestol+kahweol per cup. Caturra-specific compositional data is limited; values are extrapolated from C. arabica cultivar literature, with Caturra's compact plant morphology not documented to alter primary metabolite profiles relative to Typica parent.

Preparation & Dosage

No clinically studied dosage ranges exist for Caturra coffee in any form (extract, powder, standardized). General coffee consumption guidelines of 3-5 cups per day for C. arabica apply indirectly, but without Caturra-specific standardization data. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

L-theanine, Green tea extract, Rhodiola rosea, B-complex vitamins, Magnesium

Safety & Interactions

Caffeine doses above 400 mg/day (approximately 4 standard cups) are associated with insomnia, tachycardia, anxiety, and elevated blood pressure in sensitive individuals, with a lethal dose estimated above 10 g in healthy adults. Caturra coffee's caffeine content inhibits CYP1A2 enzyme activity, potentially raising plasma levels of clozapine, theophylline, and certain antidepressants metabolized by this pathway. Unfiltered Caturra preparations (espresso, French press) retain cafestol and kahweol, which can raise LDL cholesterol by 6–8 mg/dL with regular high-volume consumption. Pregnant individuals are advised to limit total caffeine intake to under 200 mg/day due to associations between higher intake and reduced fetal birth weight; individuals with GERD, anxiety disorders, or arrhythmias should use caution.